TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bioform AB
Closing information (x1000 NOK)
Closing information | 2024/08 | 2023/08 | 2022/08 |
Turnover |
1,277
|
1,411 | |
Financial expenses |
17
|
8 | |
Earnings before taxes |
486
|
436 | |
EBITDA |
529
|
479 | |
Total assets |
2,015
|
2,090 | |
Current assets |
1,857
|
1,510 | |
Current liabilities |
114
|
143 | |
Equity capital |
1,746
|
1,455 | |
- share capital |
98
|
92 | |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2024/08 | 2023/08 | 2022/08 |
Solvency |
86.7%
|
69.6% | |
Turnover per employee |
1,277
|
1,411 | |
Profit as a percentage of turnover |
38.1%
|
30.9% | |
Return on assets (ROA) |
25.0%
|
21.2% | |
Current ratio |
1628.9%
|
1055.9% | |
Return on equity (ROE) |
27.8%
|
30.0% | |
Change turnover |
-219
|
60 | |
Change turnover % |
-2%
|
-15%
|
4% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/08 | 2023/08 | 2022/08 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.